These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 9041721

  • 1. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
    Pereira J, Quiroga T, Goycoolea M, Muñoz B, Hidalgo P, Kaltwasser G, Mezzano D.
    Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
    [Abstract] [Full Text] [Related]

  • 2. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ.
    Rev Invest Clin; 1996 Jun; 48(3):223-9. PubMed ID: 8966383
    [Abstract] [Full Text] [Related]

  • 3. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ, Mirochnik O, McDonald D.
    Br J Biomed Sci; 1999 Jun; 56(1):23-33. PubMed ID: 10492912
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V, Leone G.
    Haematologica; 1995 Jun; 80(4):344-56. PubMed ID: 7590506
    [Abstract] [Full Text] [Related]

  • 6. [National evaluation of the diagnosis of activated protein C resistance].
    Montiel-Manzano G, de la Peña-Díaz A, Majluf-Cruz A, Cesarman-Maus G, Corona-de la Peña N, Cruz-Cruz D, Gaminio E, Martínez-Murillo C, Mayagoitia T, Miranda-Peralta E, Poblete T, Quintana-Martínez S, Ramírez R, Razo D, Ruiz de Chávez-Ochoa A, Reyes-Núñez VA, Salazar R, Vicencio-Santiago GV, Villa R.
    Rev Invest Clin; 2003 Jun; 55(3):358-69. PubMed ID: 14515684
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S, Klinke S, von Depka Prondzinski M, Kreuz W, Ganser A, Scharrer I.
    Dtsch Med Wochenschr; 1999 Jun 25; 124(25-26):783-7. PubMed ID: 10414227
    [Abstract] [Full Text] [Related]

  • 9. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B, Schinco P, Pannocchia A, Giorgianni A, Borchiellini A, Tamponi G, Pileri A.
    Thromb Haemost; 1997 Sep 25; 78(3):1042-8. PubMed ID: 9308751
    [Abstract] [Full Text] [Related]

  • 10. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF, Lensen RP, Bertina RM.
    Thromb Haemost; 1997 Feb 25; 77(2):252-7. PubMed ID: 9157576
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B.
    Semin Hematol; 1997 Jul 25; 34(3):217-34. PubMed ID: 9241707
    [Abstract] [Full Text] [Related]

  • 13. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1997 Jul 25; 78(1):483-8. PubMed ID: 9198201
    [Abstract] [Full Text] [Related]

  • 14. Factor V Leiden mutation in one family of Chinese origin.
    Wu J, Gu J, Xu J, Wang J, Sun Z, Smirnov MD, Morrissey JH, Esmon N.
    Chin Med J (Engl); 2001 Apr 25; 114(4):379-81. PubMed ID: 11780458
    [Abstract] [Full Text] [Related]

  • 15. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B.
    Semin Thromb Hemost; 1999 Apr 25; 25(3):273-89. PubMed ID: 10443959
    [Abstract] [Full Text] [Related]

  • 16. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I.
    Ann Acad Med Stetin; 2002 Apr 25; 48():179-93. PubMed ID: 14601477
    [Abstract] [Full Text] [Related]

  • 17. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z, Seligsohn U, Zivelin A, Eldor A.
    Harefuah; 1995 Jul 25; 129(1-2):1-5, 80. PubMed ID: 7557699
    [Abstract] [Full Text] [Related]

  • 18. Activated protein C resistance: molecular mechanisms.
    Griffin JH, Heeb MJ, Kojima Y, Fernández JA, Kojima K, Hackeng TM, Greengard JS.
    Thromb Haemost; 1995 Jul 25; 74(1):444-8. PubMed ID: 8578503
    [Abstract] [Full Text] [Related]

  • 19. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B.
    J Intern Med Suppl; 1997 Jul 25; 740():1-8. PubMed ID: 9350175
    [Abstract] [Full Text] [Related]

  • 20. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH.
    Nature; 1994 May 05; 369(6475):64-7. PubMed ID: 8164741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.